IRIS
ROSSETTI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.269
NA - Nord America 2.616
AS - Asia 508
SA - Sud America 29
AF - Africa 13
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.445
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.596
GB - Regno Unito 890
IT - Italia 772
IE - Irlanda 626
SE - Svezia 301
CN - Cina 254
FR - Francia 195
UA - Ucraina 143
DE - Germania 130
FI - Finlandia 73
VN - Vietnam 60
ES - Italia 49
SG - Singapore 39
IR - Iran 33
IN - India 32
RU - Federazione Russa 25
TR - Turchia 21
HK - Hong Kong 19
BR - Brasile 15
CA - Canada 15
CZ - Repubblica Ceca 13
PL - Polonia 11
CO - Colombia 10
NL - Olanda 10
BE - Belgio 9
PK - Pakistan 8
IL - Israele 6
PH - Filippine 6
AU - Australia 5
DK - Danimarca 5
CH - Svizzera 4
EU - Europa 4
MN - Mongolia 4
MX - Messico 4
BD - Bangladesh 3
ID - Indonesia 3
SK - Slovacchia (Repubblica Slovacca) 3
BW - Botswana 2
CL - Cile 2
CY - Cipro 2
IM - Isola di Man 2
JP - Giappone 2
KG - Kirghizistan 2
KR - Corea 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
QA - Qatar 2
RO - Romania 2
SN - Senegal 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
UG - Uganda 1
Totale 6.445
Salva come PNG Salva come JPEG
Città #
Southend 791
Dublin 610
Chandler 343
Fairfield 319
Ashburn 216
Siena 157
Menlo Park 146
Woodbridge 125
Seattle 118
Jacksonville 114
Ann Arbor 111
Cambridge 110
Wilmington 106
Houston 97
Princeton 93
Beijing 79
New York 61
Dong Ket 55
Florence 52
Helsinki 52
Nanjing 46
Rome 41
Málaga 40
Boardman 29
Milan 28
Dearborn 24
San Mateo 24
San Diego 23
Shanghai 22
Singapore 22
Moscow 19
Fremont 17
London 14
Izmir 13
Karaj 13
Los Angeles 13
Chicago 12
Catania 11
Comun Nuovo 10
Horsham 10
Washington 10
Brno 9
Brussels 9
Coventry 9
Guangzhou 9
Kowloon 9
Lancaster 9
Nanchang 9
Shenyang 9
Toronto 9
Jiaxing 8
Nottingham 8
Tianjin 8
Hebei 7
Norwalk 7
Redwood City 7
San Francisco 7
Zhengzhou 7
Aachen 6
Amsterdam 6
Central 6
Falls Church 6
Jinan 6
Laguna Beach 6
Lappeenranta 6
Paris 6
Perugia 6
Phoenix 6
Pisa 6
Tehran 6
Bologna 5
Brescia 5
Chia 5
Hyderabad 5
Ningbo 5
Stanford 5
Taizhou 5
Verona 5
Barolo 4
Carrara 4
Corby 4
Delhi 4
Fiesole 4
Frankfurt am Main 4
Gorizia 4
Grosseto 4
Hangzhou 4
Ho Chi Minh City 4
Lanzhou 4
Multan 4
Mumbai 4
Munich 4
Osimo 4
Padova 4
Poggibonsi 4
Roccagorga 4
Saint-Fons 4
Segrate 4
Ulan Bator 4
Warsaw 4
Totale 4.536
Salva come PNG Salva come JPEG
Nome #
Staphylococcus aureus vaccine preclinical and clinical development: current state of the art 339
Listeria meningoencephalitis and anti-GQ1b antibody syndrome 254
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 210
Virological and Immunological Response to Antiretroviral Regimens Containing Maraviroc in HIV Type 1-Infected Patients in Clinical Practice: Role of Different Tropism Testing Results and of Concomitant Treatments 194
Antirheumatic agents in covid-19: is IL-6 the right target? 182
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 180
Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor 177
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 176
Genetic mechanisms of critical illness in COVID-19 175
First report of spondylodiscitis due to vancomycin heteroresistant Staphylococcus capitis in immunocompetent host 171
null 171
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 167
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 164
Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients 163
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 161
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy 158
Un caso di “insolita” spondilodiscite da Staphylococcus capitis 157
HCMV infection in renal transplant recipients: a retrospective cohort study 150
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 145
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 144
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 138
FALLIMENTO VIROLOGICO PRECOCE CON SELEZIONE RAPIDA DI FARMACORESISTENZA IN UN PAZIENTE CON HCV GENOTIPO 1, TRATTATO CON PEGINTERFERON, RIBAVIRINA E TELAPREVIR 132
MIASI CAVITARIA A LOCALIZZAZIONE NASALE DA OESTRUS OVIS: UN CASO CLINICO 131
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 127
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 124
Serial KL-6 measurements in COVID-19 patients 117
null 115
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 111
Mapping the human genetic architecture of COVID-19 107
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 106
Il ruolo dell'infezione da CMV e del suo monitoraggio attivo nella nuova era dei trapianti di rene: risultati di una coorte completa 104
Which screening for Leishmania infantum in asymptomatic blood donors? 97
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 93
Laboratory diagnosis of Mycoplasma pneumoniae infections: data analysis from clinical practice 92
Gestione clinica di effetti collaterali multipli in un paziente con epatite cronica da HCV in trattamento con terapia triplice comprendente telaprevir 90
Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia 86
Infezione da Mycobacterium marinum: le difficoltà diagnostiche e terapeutiche di un caso raro 84
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection 81
Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA 78
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: A multi-cohort study 78
null 75
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 74
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 74
An explainable model of host genetic interactions linked to COVID-19 severity 70
Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy 62
Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection 58
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 57
Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: Results from a European multi-cohort study 52
Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe 52
Whole-genome sequencing reveals host factors underlying critical COVID-19 45
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019 43
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 40
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV 38
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 36
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients 32
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies 27
Clinical and molecular characterization of COVID-19 hospitalized patients 27
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study 26
null 14
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 9
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 9
Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network) 6
Totale 6.655
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.631
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020846 88 38 82 121 56 71 76 91 57 86 34 46
2020/20211.048 36 59 43 68 111 87 77 123 129 105 94 116
2021/20221.029 95 94 49 99 49 38 54 54 79 96 106 216
2022/20231.366 66 146 169 143 101 221 79 130 133 77 61 40
2023/20241.346 44 49 121 81 73 315 372 62 12 57 60 100
2024/202567 67 0 0 0 0 0 0 0 0 0 0 0
Totale 6.655